Pomahope 1 mg Capsule | 21 Capsules in 1 Bottle

Introduction of Pomahope 1 mg Capsule

Pomahope 1 mg Capsule is an anticancer medicine that belongs to a class of drugs called immunomodulatory agents. Pomahope Capsule is used to treat multiple myeloma (a type of blood cancer) in patients who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor.

Pomahope 1 Capsule can cause various side effects, including fatigue, fever, bone pain, muscle cramps, and diarrhoea. Additionally, it may decrease the number of red and white blood cells in the blood, making the patient more susceptible to infections. Regular monitoring through blood tests is necessary to check the levels of blood cells, as well as heart, liver, and uric acid levels.

Pomahope can be taken with or without food, but it is recommended to take it at the same time each day for optimal results. Dosage and frequency of use will be determined by your doctor based on your specific condition and may change over time. It is important that you follow your doctor's instructions and do not change the dosage or frequency of intake without their guidance. Taking Pomahope 1 mg Capsule in the wrong or excessive amounts may cause serious side effects. It may take several weeks or months for the full effects of treatment to appear, but you should not stop taking it without consulting your doctor.

Pomahope has not been established as safe and effective for use in children below the age of 18.

Uses of Pomahope 1 mg Capsule

​Multiple Myeloma (A type of blood cancer): Pomahope is used in the treatment of multiple myeloma a type of blood cancer that affects plasma cells in the bone marrow. Symptoms of multiple myeloma can include fatigue, weakness, weight loss, anaemia, etc.

Benefits of Pomahope 1 mg Capsule

Pomahope shown to be effective in improving response rates in patients with relapsed or refractory multiple myeloma, particularly when used in combination with other treatments such as dexamethasone.

Pomahope 1 mg Capsule has been reported to have fewer side effects compared to other treatments for multiple myelomas, such as thalidomide and lenalidomide.

Pomahope 1 mg improve the quality of life for patients with multiple myeloma by reducing symptoms such as bone pain and fatigue.

For patients with relapsed or refractory multiple myeloma, Pomahope Capsule offers a new treatment option that may be more effective than previous treatments.

Side Effects of Pomahope 1 mg Capsule

Like all medication, Pomahope 1 mg Capsule may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.

Most Common Side Effects of Pomahope 1 mg Capsule

• Weakness
• Itching
• Fever
• Redness
• Blackish stool
• Bloody urine
• Muscle Spasm
• ​BodyacheSwelling of face, hands, legs, feet
• Bloating of abdomen
  

Common Side Effects of Pomahope 1 mg Capsule

• Brain infection ( Memory loss, seizure, vision changes, Slurred speech, Lack of coordination)
• Liver Disease
• Severe abdominal pain, Yellowish eyes and skin
• Continuous Nausea and vomiting
• Breathing difficulty
• Severe Dizziness

How to Use Pomahope 1 mg Capsule?

​​​Pomahope can be taken with or without food, but it is recommended to take it simultaneously each day for optimal results. Your doctor will determine dosage and frequency of use based on your specific condition which may change over time. You must follow your doctor's instructions and not change the dosage or frequency of intake without their guidance.

How Pomahope 1 mg Capsule Works?

Pomahope 1 Capsule is an immunomodulatory drug that works by targeting the immune system and inhibiting the growth of cancer cells. It does this by binding to a specific receptor on the surface of immune cells called carbon, which is involved in the regulation of immune cell growth and survival. Pomahope 1 mg works by inhibiting the growth of cancer cells in several ways. It interferes with the formation of new blood vessels that cancer cells need to grow and spread. It also stimulates the immune system to attack and destroy cancer cells. Additionally, Pomahope can cause cancer cells to self-destruct, a process called apoptosis. Overall, Pomahope 1 Capsule works by targeting the immune system and inhibiting the growth and spread of cancer cells, making it an important treatment option for multiple myeloma and other cancers.

Safety Advices Pomahope 1 mg Capsule

Breastfeeding

Unsafe

Driving

Unsafe

Kidney

Use with Caution

Alcohol

Unsafe

Pregnancy

Unsafe

Liver

Use with Caution

References

1. Pomalidomide, Package leaflet: Information for the patient, Celgene Distribution B.V. Orteliuslaan 1000, 3528 BD, Utrecht Netherlands, Product Leaflet 

2. Pomalidomide, Celgene Corporation, Summit, Product Leaflet 

3. Pomalidomide capsules – NZ Data Sheet,[Date of Updated 31 January 2022], Product Monograph 

4. Pomalidomide capsules, European Medicines Agency: UK, Product Leaflet